stoxline Quote Chart Rank Option Currency Glossary
  
(PSDV)
  0 (0%)    04-25 05:56
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-04-24 4:46:39 PM
Short term     
Mid term     
Targets 6-month :  35.81 1-year :  36.79
Resists First :  30.66 Second :  31.5
Pivot price 30.13
Supports First :  29.31 Second :  24.39
MAs MA(5) :  29.87 MA(20) :  30.39
MA(100) :  29.64 MA(250) :  28.45
MACD MACD :  -0.2 Signal :  -0.1
%K %D K(14,3) :  36.3 D(3) :  27.5
RSI RSI(14): 49.8
52-week High :  31.5 Low :  25.3
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SPDV ] has closed below upper band by 47.9%. Bollinger Bands are 39.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 30.2 - 30.29 30.29 - 30.39
Low: 29.79 - 29.9 29.9 - 30.03
Close: 29.98 - 30.15 30.15 - 30.34
Company Description

Headline News

Thu, 18 Feb 2021
PSD Virtual ending, will be replaced by Poudre Global Academy Virtual - Coloradoan

Fri, 04 Dec 2020
BMW iX3 and iX will be priced to compete - carsales.com.au - carsales.com.au

Thu, 27 Feb 2020
Baxter Launches Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical ... - Business Wire

Thu, 26 Sep 2019
Venezuelan Central Bank is Considering Holding Bitcoin and Ether - Cointelegraph

Thu, 29 Mar 2018
pSivida buys Icon Bioscience and rebrands as EyePoint Pharmaceuticals - Mass Device

Tue, 16 Aug 2016
PSivida says PhIII results of uveitis drug Medidur exceed expectations - FiercePharma

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android